Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization

Por Hsu Hui-Chi, Chang Kai-Ming, Kao Kuo-Jang, Huang Andrew T
Publicado em 2011-04-01

Correlation of microarray-based breast cancer molecular subtypes and clinical outcomes: implications for treatment optimization

Por Kao, Kuo-Jang, Chang, Kai-Ming, Hsu, Hui-Chi, Huang, Andrew T
Publicado em 2011

PERSISTENCE OF LYMPHOCYTOTOXIC ANTIBODIES IN PATIENTS IN THE TRIAL TO REDUCE ALLOIMMUNIZATION TO PLATELETS: IMPLICATIONS FOR USING MODIFIED BLOOD PRODUCTS

Por Slichter, Sherrill J., Bolgiano, Douglas, Kao, Kuo-Jang, Kickler, Thomas S., McFarland, Janice, McCullough, Jeffrey, Woodson, Robert
Publicado em 2011

Plasmalemmal Vesicle Associated Protein (PLVAP) as a therapeutic target for treatment of hepatocellular carcinoma

Por Wang, Yun-Hsin, Cheng, Tsung-Yen, Chen, Ta-Yuan, Chang, Kai-Ming, Chuang, Vincent P, Kao, Kuo-Jang
Publicado no BMC Cancer (2014)

Factors affecting posttransfusion platelet increments, platelet refractoriness, and platelet transfusion intervals in thrombocytopenic patients

Por Slichter, Sherrill J., Davis, Kathryn, Enright, Helen, Braine, Hayden, Gernsheimer, Terry, Kao, Kuo-Jang, Kickler, Thomas, Lee, Edward, McFarland, Janice, McCullough, Jeffrey, Rodey, Glenn, Schiffer, Charles A., Woodson, Robert
Publicado em 2005

Characterization of the biological activity of a potent small molecule Hec1 inhibitor TAI-1

Por Huang, Lynn YL, Lee, Ying-Shuan, Huang, Jiann-Jyh, Chang, Chia-chi, Chang, Jia-Ming, Chuang, Shih-Hsien, Kao, Kuo-Jang, Tsai, Yung-Jen, Tsai, Pei-Yi, Liu, Chia-Wei, Lin, Her-Sheng, Lau, Johnson YN
Publicado em 2014